{"id":76210,"date":"2020-11-10T00:17:39","date_gmt":"2020-11-10T05:17:39","guid":{"rendered":"https:\/\/www.hedgeco.net\/news\/?p=76210"},"modified":"2020-11-10T00:24:07","modified_gmt":"2020-11-10T05:24:07","slug":"u-s-allows-emergency-use-of-eli-lillys-covid-antibody-therapy","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/11\/2020\/u-s-allows-emergency-use-of-eli-lillys-covid-antibody-therapy.html","title":{"rendered":"U.S. allows emergency use of Eli Lilly\u2019s Covid antibody therapy"},"content":{"rendered":"\n<p>(CNBC) The U.S. Food and Drug Administration on Monday authorized emergency use of <a href=\"https:\/\/www.cnbc.com\/quotes\/?symbol=LLY\">Eli Lilly<\/a>\u2019s experimental Covid-19 antibody treatment for non-hospitalized patients older than 65 or who have certain chronic medical conditions. The FDA said its emergency use authorization (EUA) was based on clinical trials showing that the treatment, bamlanivimab, reduced the need for hospitalization or emergency room visits in Covid-19 patients at high risk of disease progression.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.cnbc.com\/2020\/11\/09\/us-allows-emergency-use-of-eli-lillys-covid-antibody-therapy.html\">To read this article:<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(CNBC) The U.S. Food and Drug Administration on Monday authorized emergency use of Eli Lilly\u2019s experimental Covid-19 antibody treatment for non-hospitalized patients older than 65 or who have certain chronic medical conditions. The FDA said its emergency use authorization (EUA) [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-76210","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/76210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=76210"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/76210\/revisions"}],"predecessor-version":[{"id":76211,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/76210\/revisions\/76211"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=76210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=76210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=76210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}